111 related articles for article (PubMed ID: 1714791)
1. Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma.
Pappo A; Schneider NR; Sanders JM; Buchanan GR
Cancer; 1991 Sep; 68(6):1373-5. PubMed ID: 1714791
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms.
Rosen G
Recent Results Cancer Res; 1986; 103():148-57. PubMed ID: 2426747
[No Abstract] [Full Text] [Related]
3. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
4. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
5. Secondary cerebral astrocytoma 3 years after diagnosis of primary osteogenic sarcoma: a case report.
Lanning M; Heikkinen E; Lanning P
Pediatr Hematol Oncol; 1987; 4(2):153-5. PubMed ID: 2484649
[TBL] [Abstract][Full Text] [Related]
6. The multi-institutional osteosarcoma study: an update.
Link MP
Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
[No Abstract] [Full Text] [Related]
7. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
8. [Current aspects of the treatment of osteogenic sarcoma].
Glukhovskaia IIu; Tolstopiatov BA; Butenko AK; Konovalenko VF
Klin Khir; 1995; (5):32-3. PubMed ID: 8646629
[No Abstract] [Full Text] [Related]
9. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Chuman H; Fukuma H; Beppu Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460
[TBL] [Abstract][Full Text] [Related]
11. [The reproduction in France of Rosen's protocol for osteosarcomas].
Brunat-Mentigny M; Demaille MC; Quitana E; Olive D; Bachelot C; Boitetot A; Gentet JC; Noir P; Roche H; Thyss JP
Bull Cancer; 1988; 75(2):201-6. PubMed ID: 2451955
[TBL] [Abstract][Full Text] [Related]
12. Ten years' experience in patients with osteogenic sarcoma in Finland.
Elomaa I; Siimes MA; Blomqvist C; Karaharju E; Ryöppy S; Laasonen E; Holmström T
Eur J Surg Oncol; 1990 Apr; 16(2):147-52. PubMed ID: 1691110
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
[TBL] [Abstract][Full Text] [Related]
14. Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Fenaux P; Jouet JP; Bauters F; Lai JL; Lepelley P
J Clin Oncol; 1987 Aug; 5(8):1304-5. PubMed ID: 2442320
[No Abstract] [Full Text] [Related]
15. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U
J Clin Oncol; 1984 Jun; 2(6):617-24. PubMed ID: 6202851
[TBL] [Abstract][Full Text] [Related]
17. [Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Kalifa C; Mlika N; Dubousset J; Contesso G; Vanel D; Lumbroso J
Bull Cancer; 1988; 75(2):207-11. PubMed ID: 2451956
[TBL] [Abstract][Full Text] [Related]
18. What has adjuvant chemotherapy of osteosarcoma achieved? Discussion paper.
Souhami RL
J R Soc Med; 1983 Nov; 76(11):943-6. PubMed ID: 6195337
[No Abstract] [Full Text] [Related]
19. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Meyers PA; Gorlick R; Heller G; Casper E; Lane J; Huvos AG; Healey JH
J Clin Oncol; 1998 Jul; 16(7):2452-8. PubMed ID: 9667263
[TBL] [Abstract][Full Text] [Related]
20. [Alternative chemotherapy of malignant bone neoplasms in children].
Jurczyk-Procyk S; Perek D
Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]